Loading…

Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight

NU172-a 26-mer oligonucleotide able to bind exosite I of human thrombin and inhibit its activity-was the first aptamer to reach Phase II clinical studies as an anticoagulant in heart disease treatments. With the aim of favoring its functional duplex-quadruplex conformation and thus improving its enz...

Full description

Saved in:
Bibliographic Details
Published in:International journal of molecular sciences 2020-05, Vol.21 (11), p.3860
Main Authors: Riccardi, Claudia, Meyer, Albert, Vasseur, Jean-Jacques, Cavasso, Domenico, Russo Krauss, Irene, Paduano, Luigi, Morvan, François, Montesarchio, Daniela
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223
cites cdi_FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223
container_end_page
container_issue 11
container_start_page 3860
container_title International journal of molecular sciences
container_volume 21
creator Riccardi, Claudia
Meyer, Albert
Vasseur, Jean-Jacques
Cavasso, Domenico
Russo Krauss, Irene
Paduano, Luigi
Morvan, François
Montesarchio, Daniela
description NU172-a 26-mer oligonucleotide able to bind exosite I of human thrombin and inhibit its activity-was the first aptamer to reach Phase II clinical studies as an anticoagulant in heart disease treatments. With the aim of favoring its functional duplex-quadruplex conformation and thus improving its enzymatic stability, as well as its thrombin inhibitory activity, herein a focused set of cyclic NU172 analogues-obtained by connecting its 5'- and 3'-extremities with flexible linkers-was synthesized. Two different chemical approaches were exploited in the cyclization procedure, one based on the oxime ligation method and the other on Cu(I)-assisted azide-alkyne cycloaddition (CuAAC), affording NU172 analogues including circularizing linkers with different length and chemical nature. The resulting cyclic NU172 derivatives were characterized using several biophysical techniques (ultraviolet (UV) and circular dichroism (CD) spectroscopies, gel electrophoresis) and then investigated for their serum resistance and anticoagulant activity in vitro. All the cyclic NU172 analogues showed higher thermal stability and nuclease resistance compared to unmodified NU172. These favorable properties were, however, associated with reduced-even though still significant-anticoagulant activity, suggesting that the conformational constraints introduced upon cyclization were somehow detrimental for protein recognition. These results provide useful information for the design of improved analogues of NU172 and related duplex-quadruplex structures.
doi_str_mv 10.3390/ijms21113860
format article
fullrecord <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_d93165f1d3ee4693a216d6bfff898992</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_d93165f1d3ee4693a216d6bfff898992</doaj_id><sourcerecordid>2409195148</sourcerecordid><originalsourceid>FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223</originalsourceid><addsrcrecordid>eNpdkktvEzEUhS0Eog_YsUazBKkB-9rjsVkghfBopAgW0LXl8SPjaDJO7Uml8OvrJKVKWfk-zv2ubR2E3hD8gVKJP4bVOgMhhAqOn6FzwgAmGPPm-Ul8hi5yXmEMFGr5Ep1RYKIWRJwj_9XlsByuqt-7YexKnCs92GrW6aTN6FL4q8cQhyr6arYzfTDVzxvSQDUddB-XW5c_VdPqS4ibbpeD0f1huuSleUjnQ8F34yv0wus-u9cP5yW6-f7tz-x6svj1Yz6bLiaGCTZOjGMWe-tASyfrRmPTlJtK7LhpiQZneWM8azEFak0jXNNKZkG3NScUEwB6ieZHro16pTYprHXaqaiDOhRiWiqdxmB6p6ykhNeeWOoc45JqINzy1nsvpJByz_p8ZG227dpZ44Yx6f4J9GlnCJ1axjvVUAIYcAG8PwK6_8aupwu1r2GQmDGo70jRvntYluJt-dZRrUM2ru_14OI2K2BYElkTJor06ig1KeacnH9kE6z2llCnlijyt6fPeBT_8wC9BxWPsXk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2409195148</pqid></control><display><type>article</type><title>Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight</title><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><source>PubMed Central</source><creator>Riccardi, Claudia ; Meyer, Albert ; Vasseur, Jean-Jacques ; Cavasso, Domenico ; Russo Krauss, Irene ; Paduano, Luigi ; Morvan, François ; Montesarchio, Daniela</creator><creatorcontrib>Riccardi, Claudia ; Meyer, Albert ; Vasseur, Jean-Jacques ; Cavasso, Domenico ; Russo Krauss, Irene ; Paduano, Luigi ; Morvan, François ; Montesarchio, Daniela</creatorcontrib><description>NU172-a 26-mer oligonucleotide able to bind exosite I of human thrombin and inhibit its activity-was the first aptamer to reach Phase II clinical studies as an anticoagulant in heart disease treatments. With the aim of favoring its functional duplex-quadruplex conformation and thus improving its enzymatic stability, as well as its thrombin inhibitory activity, herein a focused set of cyclic NU172 analogues-obtained by connecting its 5'- and 3'-extremities with flexible linkers-was synthesized. Two different chemical approaches were exploited in the cyclization procedure, one based on the oxime ligation method and the other on Cu(I)-assisted azide-alkyne cycloaddition (CuAAC), affording NU172 analogues including circularizing linkers with different length and chemical nature. The resulting cyclic NU172 derivatives were characterized using several biophysical techniques (ultraviolet (UV) and circular dichroism (CD) spectroscopies, gel electrophoresis) and then investigated for their serum resistance and anticoagulant activity in vitro. All the cyclic NU172 analogues showed higher thermal stability and nuclease resistance compared to unmodified NU172. These favorable properties were, however, associated with reduced-even though still significant-anticoagulant activity, suggesting that the conformational constraints introduced upon cyclization were somehow detrimental for protein recognition. These results provide useful information for the design of improved analogues of NU172 and related duplex-quadruplex structures.</description><identifier>ISSN: 1422-0067</identifier><identifier>ISSN: 1661-6596</identifier><identifier>EISSN: 1422-0067</identifier><identifier>DOI: 10.3390/ijms21113860</identifier><identifier>PMID: 32485818</identifier><language>eng</language><publisher>Switzerland: MDPI</publisher><subject>Analytical chemistry ; Anticoagulants - chemical synthesis ; Aptamers, Nucleotide - chemical synthesis ; biophysical characterization ; Chemical Sciences ; Circular Dichroism ; cyclization ; Cycloaddition Reaction - methods ; DNA aptamers ; duplex/quadruplex ; Fibrinogen - chemistry ; G-quadruplex ; G-Quadruplexes ; Medicinal Chemistry ; NU172 ; Organic chemistry ; Oximes - chemistry ; Ultraviolet Rays</subject><ispartof>International journal of molecular sciences, 2020-05, Vol.21 (11), p.3860</ispartof><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2020 by the authors. 2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223</citedby><cites>FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223</cites><orcidid>0000-0002-7182-0757 ; 0000-0001-6295-6911 ; 0000-0001-8124-6034 ; 0000-0002-1105-4237 ; 0000-0001-5077-0028 ; 0000-0002-4379-6139</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312020/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312020/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,37013,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32485818$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.science/hal-02904425$$DView record in HAL$$Hfree_for_read</backlink></links><search><creatorcontrib>Riccardi, Claudia</creatorcontrib><creatorcontrib>Meyer, Albert</creatorcontrib><creatorcontrib>Vasseur, Jean-Jacques</creatorcontrib><creatorcontrib>Cavasso, Domenico</creatorcontrib><creatorcontrib>Russo Krauss, Irene</creatorcontrib><creatorcontrib>Paduano, Luigi</creatorcontrib><creatorcontrib>Morvan, François</creatorcontrib><creatorcontrib>Montesarchio, Daniela</creatorcontrib><title>Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight</title><title>International journal of molecular sciences</title><addtitle>Int J Mol Sci</addtitle><description>NU172-a 26-mer oligonucleotide able to bind exosite I of human thrombin and inhibit its activity-was the first aptamer to reach Phase II clinical studies as an anticoagulant in heart disease treatments. With the aim of favoring its functional duplex-quadruplex conformation and thus improving its enzymatic stability, as well as its thrombin inhibitory activity, herein a focused set of cyclic NU172 analogues-obtained by connecting its 5'- and 3'-extremities with flexible linkers-was synthesized. Two different chemical approaches were exploited in the cyclization procedure, one based on the oxime ligation method and the other on Cu(I)-assisted azide-alkyne cycloaddition (CuAAC), affording NU172 analogues including circularizing linkers with different length and chemical nature. The resulting cyclic NU172 derivatives were characterized using several biophysical techniques (ultraviolet (UV) and circular dichroism (CD) spectroscopies, gel electrophoresis) and then investigated for their serum resistance and anticoagulant activity in vitro. All the cyclic NU172 analogues showed higher thermal stability and nuclease resistance compared to unmodified NU172. These favorable properties were, however, associated with reduced-even though still significant-anticoagulant activity, suggesting that the conformational constraints introduced upon cyclization were somehow detrimental for protein recognition. These results provide useful information for the design of improved analogues of NU172 and related duplex-quadruplex structures.</description><subject>Analytical chemistry</subject><subject>Anticoagulants - chemical synthesis</subject><subject>Aptamers, Nucleotide - chemical synthesis</subject><subject>biophysical characterization</subject><subject>Chemical Sciences</subject><subject>Circular Dichroism</subject><subject>cyclization</subject><subject>Cycloaddition Reaction - methods</subject><subject>DNA aptamers</subject><subject>duplex/quadruplex</subject><subject>Fibrinogen - chemistry</subject><subject>G-quadruplex</subject><subject>G-Quadruplexes</subject><subject>Medicinal Chemistry</subject><subject>NU172</subject><subject>Organic chemistry</subject><subject>Oximes - chemistry</subject><subject>Ultraviolet Rays</subject><issn>1422-0067</issn><issn>1661-6596</issn><issn>1422-0067</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNpdkktvEzEUhS0Eog_YsUazBKkB-9rjsVkghfBopAgW0LXl8SPjaDJO7Uml8OvrJKVKWfk-zv2ubR2E3hD8gVKJP4bVOgMhhAqOn6FzwgAmGPPm-Ul8hi5yXmEMFGr5Ep1RYKIWRJwj_9XlsByuqt-7YexKnCs92GrW6aTN6FL4q8cQhyr6arYzfTDVzxvSQDUddB-XW5c_VdPqS4ibbpeD0f1huuSleUjnQ8F34yv0wus-u9cP5yW6-f7tz-x6svj1Yz6bLiaGCTZOjGMWe-tASyfrRmPTlJtK7LhpiQZneWM8azEFak0jXNNKZkG3NScUEwB6ieZHro16pTYprHXaqaiDOhRiWiqdxmB6p6ykhNeeWOoc45JqINzy1nsvpJByz_p8ZG227dpZ44Yx6f4J9GlnCJ1axjvVUAIYcAG8PwK6_8aupwu1r2GQmDGo70jRvntYluJt-dZRrUM2ru_14OI2K2BYElkTJor06ig1KeacnH9kE6z2llCnlijyt6fPeBT_8wC9BxWPsXk</recordid><startdate>20200529</startdate><enddate>20200529</enddate><creator>Riccardi, Claudia</creator><creator>Meyer, Albert</creator><creator>Vasseur, Jean-Jacques</creator><creator>Cavasso, Domenico</creator><creator>Russo Krauss, Irene</creator><creator>Paduano, Luigi</creator><creator>Morvan, François</creator><creator>Montesarchio, Daniela</creator><general>MDPI</general><general>MDPI AG</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-7182-0757</orcidid><orcidid>https://orcid.org/0000-0001-6295-6911</orcidid><orcidid>https://orcid.org/0000-0001-8124-6034</orcidid><orcidid>https://orcid.org/0000-0002-1105-4237</orcidid><orcidid>https://orcid.org/0000-0001-5077-0028</orcidid><orcidid>https://orcid.org/0000-0002-4379-6139</orcidid></search><sort><creationdate>20200529</creationdate><title>Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight</title><author>Riccardi, Claudia ; Meyer, Albert ; Vasseur, Jean-Jacques ; Cavasso, Domenico ; Russo Krauss, Irene ; Paduano, Luigi ; Morvan, François ; Montesarchio, Daniela</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Analytical chemistry</topic><topic>Anticoagulants - chemical synthesis</topic><topic>Aptamers, Nucleotide - chemical synthesis</topic><topic>biophysical characterization</topic><topic>Chemical Sciences</topic><topic>Circular Dichroism</topic><topic>cyclization</topic><topic>Cycloaddition Reaction - methods</topic><topic>DNA aptamers</topic><topic>duplex/quadruplex</topic><topic>Fibrinogen - chemistry</topic><topic>G-quadruplex</topic><topic>G-Quadruplexes</topic><topic>Medicinal Chemistry</topic><topic>NU172</topic><topic>Organic chemistry</topic><topic>Oximes - chemistry</topic><topic>Ultraviolet Rays</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Riccardi, Claudia</creatorcontrib><creatorcontrib>Meyer, Albert</creatorcontrib><creatorcontrib>Vasseur, Jean-Jacques</creatorcontrib><creatorcontrib>Cavasso, Domenico</creatorcontrib><creatorcontrib>Russo Krauss, Irene</creatorcontrib><creatorcontrib>Paduano, Luigi</creatorcontrib><creatorcontrib>Morvan, François</creatorcontrib><creatorcontrib>Montesarchio, Daniela</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>International journal of molecular sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Riccardi, Claudia</au><au>Meyer, Albert</au><au>Vasseur, Jean-Jacques</au><au>Cavasso, Domenico</au><au>Russo Krauss, Irene</au><au>Paduano, Luigi</au><au>Morvan, François</au><au>Montesarchio, Daniela</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight</atitle><jtitle>International journal of molecular sciences</jtitle><addtitle>Int J Mol Sci</addtitle><date>2020-05-29</date><risdate>2020</risdate><volume>21</volume><issue>11</issue><spage>3860</spage><pages>3860-</pages><issn>1422-0067</issn><issn>1661-6596</issn><eissn>1422-0067</eissn><abstract>NU172-a 26-mer oligonucleotide able to bind exosite I of human thrombin and inhibit its activity-was the first aptamer to reach Phase II clinical studies as an anticoagulant in heart disease treatments. With the aim of favoring its functional duplex-quadruplex conformation and thus improving its enzymatic stability, as well as its thrombin inhibitory activity, herein a focused set of cyclic NU172 analogues-obtained by connecting its 5'- and 3'-extremities with flexible linkers-was synthesized. Two different chemical approaches were exploited in the cyclization procedure, one based on the oxime ligation method and the other on Cu(I)-assisted azide-alkyne cycloaddition (CuAAC), affording NU172 analogues including circularizing linkers with different length and chemical nature. The resulting cyclic NU172 derivatives were characterized using several biophysical techniques (ultraviolet (UV) and circular dichroism (CD) spectroscopies, gel electrophoresis) and then investigated for their serum resistance and anticoagulant activity in vitro. All the cyclic NU172 analogues showed higher thermal stability and nuclease resistance compared to unmodified NU172. These favorable properties were, however, associated with reduced-even though still significant-anticoagulant activity, suggesting that the conformational constraints introduced upon cyclization were somehow detrimental for protein recognition. These results provide useful information for the design of improved analogues of NU172 and related duplex-quadruplex structures.</abstract><cop>Switzerland</cop><pub>MDPI</pub><pmid>32485818</pmid><doi>10.3390/ijms21113860</doi><orcidid>https://orcid.org/0000-0002-7182-0757</orcidid><orcidid>https://orcid.org/0000-0001-6295-6911</orcidid><orcidid>https://orcid.org/0000-0001-8124-6034</orcidid><orcidid>https://orcid.org/0000-0002-1105-4237</orcidid><orcidid>https://orcid.org/0000-0001-5077-0028</orcidid><orcidid>https://orcid.org/0000-0002-4379-6139</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1422-0067
ispartof International journal of molecular sciences, 2020-05, Vol.21 (11), p.3860
issn 1422-0067
1661-6596
1422-0067
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_d93165f1d3ee4693a216d6bfff898992
source Publicly Available Content Database (Proquest) (PQ_SDU_P3); PubMed Central
subjects Analytical chemistry
Anticoagulants - chemical synthesis
Aptamers, Nucleotide - chemical synthesis
biophysical characterization
Chemical Sciences
Circular Dichroism
cyclization
Cycloaddition Reaction - methods
DNA aptamers
duplex/quadruplex
Fibrinogen - chemistry
G-quadruplex
G-Quadruplexes
Medicinal Chemistry
NU172
Organic chemistry
Oximes - chemistry
Ultraviolet Rays
title Design, Synthesis and Characterization of Cyclic NU172 Analogues: A Biophysical and Biological Insight
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T08%3A35%3A19IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Design,%20Synthesis%20and%20Characterization%20of%20Cyclic%20NU172%20Analogues:%20A%20Biophysical%20and%20Biological%20Insight&rft.jtitle=International%20journal%20of%20molecular%20sciences&rft.au=Riccardi,%20Claudia&rft.date=2020-05-29&rft.volume=21&rft.issue=11&rft.spage=3860&rft.pages=3860-&rft.issn=1422-0067&rft.eissn=1422-0067&rft_id=info:doi/10.3390/ijms21113860&rft_dat=%3Cproquest_doaj_%3E2409195148%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c484t-ce4d0fde2a9e957a0c724890e6cb1a2ed67cf4b0323dc78e7b94d2ab561301223%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2409195148&rft_id=info:pmid/32485818&rfr_iscdi=true